Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
GLAUKOS CorpListing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GLAUKOS CorpListing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GLAUKOS CorpListing on record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GLAUKOS CorpListing on record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GLAUKOS CorpListing on record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GLAUKOS CorpListing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GLAUKOS CorpListing on record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GLAUKOS CorpListing on record | Exercise | $800K | Unusual size | SEC | |
GLAUKOS CorpListing on record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GLAUKOS CorpListing on record | Exercise | $370.4K | Unusual size | SEC | |
GLAUKOS CorpListing on record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GLAUKOS CorpListing on record | Sell | $2.5M | Unusual size | SEC | |
Revance Therapeutics, Inc.Listing unverified | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Other | $3.6M | Unusual size | SEC | |
Revance Therapeutics, Inc.Listing unverified | Other | $404.8K | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Award | $2.2K | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Award | $2.2K | SEC | ||
GLAUKOS CorpListing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GLAUKOS CorpListing on record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Other | $17.5K | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Other | $91.5K | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Buy | $209.4K | conv 31First in 12mo | SEC |